BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33311557)

  • 1. PAI-1 derived from cancer-associated fibroblasts in esophageal squamous cell carcinoma promotes the invasion of cancer cells and the migration of macrophages.
    Sakamoto H; Koma YI; Higashino N; Kodama T; Tanigawa K; Shimizu M; Fujikawa M; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
    Lab Invest; 2021 Mar; 101(3):353-368. PubMed ID: 33311557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma.
    Higashino N; Koma YI; Hosono M; Takase N; Okamoto M; Kodaira H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
    Lab Invest; 2019 Jun; 99(6):777-792. PubMed ID: 30683902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIC-5 in cancer-associated fibroblasts contributes to esophageal squamous cell carcinoma progression.
    Du X; Xu Q; Pan D; Xu D; Niu B; Hong W; Zhang R; Li X; Chen S
    Cell Death Dis; 2019 Nov; 10(12):873. PubMed ID: 31740661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance.
    Che Y; Wang J; Li Y; Lu Z; Huang J; Sun S; Mao S; Lei Y; Zang R; Sun N; He J
    Cell Death Dis; 2018 Jul; 9(7):759. PubMed ID: 29988148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periostin in Cancer-Associated Fibroblasts Promotes Esophageal Squamous Cell Carcinoma Progression by Enhancing Cancer and Stromal Cell Migration.
    Miyako S; Koma YI; Nakanishi T; Tsukamoto S; Yamanaka K; Ishihara N; Azumi Y; Urakami S; Shimizu M; Kodama T; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
    Am J Pathol; 2024 May; 194(5):828-848. PubMed ID: 38320632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAI-1 overexpression promotes invasion and migration of esophageal squamous carcinoma cells.
    Wang D; Yang LY; Liu Z; Yu J; Zhang MJ; Zhang Y; Cai Y; Xu X; Hao JJ; Wang MR
    Yi Chuan; 2020 Mar; 42(3):287-295. PubMed ID: 32217514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma.
    Tian B; Chen X; Zhang H; Li X; Wang J; Han W; Zhang LY; Fu L; Li Y; Nie C; Zhao Y; Tan X; Wang H; Guan XY; Hong A
    Oncotarget; 2017 Jun; 8(26):42300-42313. PubMed ID: 28404945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trichostatin A promotes esophageal squamous cell carcinoma cell migration and EMT through BRD4/ERK1/2-dependent pathway.
    Liu D; Liu Y; Qi B; Gu C; Huo S; Zhao B
    Cancer Med; 2021 Aug; 10(15):5235-5245. PubMed ID: 34160902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation.
    Cai R; Wang P; Zhao X; Lu X; Deng R; Wang X; Su Z; Hong C; Lin J
    J Transl Med; 2020 Mar; 18(1):139. PubMed ID: 32216815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal Sonic Hedgehog derived from cancer-associated fibroblasts promotes proliferation and migration of esophageal squamous cell carcinoma.
    Zhao G; Li H; Guo Q; Zhou A; Wang X; Li P; Zhang S
    Cancer Med; 2020 Apr; 9(7):2500-2513. PubMed ID: 32030915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of FGFR2
    Qiu H; Zhang X; Qi J; Zhang J; Tong Y; Li L; Fu L; Qin YR; Guan X; Zhang L
    J Exp Clin Cancer Res; 2022 Aug; 41(1):240. PubMed ID: 35941662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of miR-100-5p in cancer-associated fibroblast-derived exosomes facilitates lymphangiogenesis in esophageal squamous cell carcinoma.
    Chen C; Yang C; Tian X; Liang Y; Wang S; Wang X; Shou Y; Li H; Xiao Q; Shu J; Sun M; Chen K
    Cancer Med; 2023 Jul; 12(13):14468-14483. PubMed ID: 37184125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of cancer-associated fibroblasts in esophageal squamous cell carcinoma.
    Ha SY; Yeo SY; Xuan YH; Kim SH
    PLoS One; 2014; 9(6):e99955. PubMed ID: 24945657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CAF-derived exosomes deliver LINC01410 to promote epithelial-mesenchymal transition of esophageal squamous cell carcinoma.
    Shi Z; Jiang T; Cao B; Sun X; Liu J
    Exp Cell Res; 2022 Mar; 412(2):113033. PubMed ID: 35041823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-associated fibroblast-derived PAI-1 promotes lymphatic metastasis via the induction of EndoMT in lymphatic endothelial cells.
    Wei WF; Zhou HL; Chen PY; Huang XL; Huang L; Liang LJ; Guo CH; Zhou CF; Yu L; Fan LS; Wang W
    J Exp Clin Cancer Res; 2023 Jul; 42(1):160. PubMed ID: 37415190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated fibroblasts mediated chemoresistance by a FOXO1/TGFβ1 signaling loop in esophageal squamous cell carcinoma.
    Zhang H; Xie C; Yue J; Jiang Z; Zhou R; Xie R; Wang Y; Wu S
    Mol Carcinog; 2017 Mar; 56(3):1150-1163. PubMed ID: 27769097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging role of cancer-associated fibroblasts in esophageal squamous cell carcinoma.
    Li W; Xu T; Jin H; Li M; Jia Q
    Pathol Res Pract; 2024 Jan; 253():155002. PubMed ID: 38056131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-associated fibroblasts: An emerging target against esophageal squamous cell carcinoma.
    Qiu L; Yue J; Ding L; Yin Z; Zhang K; Zhang H
    Cancer Lett; 2022 Oct; 546():215860. PubMed ID: 35948121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metallothionein 2A Expression in Cancer-Associated Fibroblasts and Cancer Cells Promotes Esophageal Squamous Cell Carcinoma Progression.
    Shimizu M; Koma YI; Sakamoto H; Tsukamoto S; Kitamura Y; Urakami S; Tanigawa K; Kodama T; Higashino N; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL3-CCR5 axis contributes to progression of esophageal squamous cell carcinoma by promoting cell migration and invasion via Akt and ERK pathways.
    Kodama T; Koma YI; Arai N; Kido A; Urakawa N; Nishio M; Shigeoka M; Yokozaki H
    Lab Invest; 2020 Sep; 100(9):1140-1157. PubMed ID: 32457351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.